papertrans
发表于 2025-3-21 19:17:59
书目名称Cancer Immunotherapy影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0221138<br><br> <br><br>书目名称Cancer Immunotherapy影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0221138<br><br> <br><br>书目名称Cancer Immunotherapy网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0221138<br><br> <br><br>书目名称Cancer Immunotherapy网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0221138<br><br> <br><br>书目名称Cancer Immunotherapy被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0221138<br><br> <br><br>书目名称Cancer Immunotherapy被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0221138<br><br> <br><br>书目名称Cancer Immunotherapy年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0221138<br><br> <br><br>书目名称Cancer Immunotherapy年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0221138<br><br> <br><br>书目名称Cancer Immunotherapy读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0221138<br><br> <br><br>书目名称Cancer Immunotherapy读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0221138<br><br> <br><br>
Blanch
发表于 2025-3-21 22:20:28
T Cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment. In this chapter, we review and summarize current knowledge regarding the function, interactions, and prognostic significance of each of these populations, as well as their dependence upon one another within the tumor microenvironment.
dominant
发表于 2025-3-22 04:08:26
http://reply.papertrans.cn/23/2212/221138/221138_3.png
NEEDY
发表于 2025-3-22 06:28:53
Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Conceptsthe lymphoid organs where they present the antigen and control the activation of B and T cells, the mediators of specific immunity. DC-based immunotherapy is explored worldwide in clinical vaccination trials with cancer patients aiming to induce or augment an antitumor immune response. The majority
打火石
发表于 2025-3-22 09:42:38
Peptide and Protein-Based Cancer Vaccinesons and early mobilization of the immune system. In cancer, tumor cells have evolved to overcome immune surveillance or grow in the presence of exhausted immune cells. However, the identification of tumor-infiltrating lymphocytes as good prognostic indicator of increased survival in cancer disease 1
圆柱
发表于 2025-3-22 14:56:48
Antigen Targeting to Dendritic Cells for Cancer Immunotherapyigrate to the draining lymph nodes where they can induce an antigen-specific T cell response. A promising strategy to induce a potent, specific, and lasting anti-tumor response is to target tumor antigens to DC in vivo. This represents a clinically generally applicable and cost-effective approach to
圆柱
发表于 2025-3-22 18:34:56
Cytokines in the Treatment of Cancertokines classified by their receptor usage. The effects of individual cytokines on immunity depend on several factors, including the local cytokine concentration, the pattern of cytokine receptor expression, and the integration of multiple signaling pathways in responding immune cells. Cytokines hav
fringe
发表于 2025-3-22 23:59:14
http://reply.papertrans.cn/23/2212/221138/221138_8.png
CRUE
发表于 2025-3-23 02:33:54
Managing Regulatory T Cells to Improve Cancer Immunotherapynt cancer histologies. Cancer Tregs not only are capable of impeding endogenous protective anti-tumor immunity from optimal functioning but are also capable of impeding the efficacy of anti-cancer immunotherapy. Tumor-associated Tregs represent heterogeneous populations, differing by their origins a
Override
发表于 2025-3-23 07:29:02
http://reply.papertrans.cn/23/2212/221138/221138_10.png